Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding in Company

18th Feb 2011 12:38

RNS Number : 5053B
United Drug PLC
18 February 2011
 



Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC[i]

This notification is for filing purposes only in accordance with Regulation 22 of the Transparency (Directive 2004/109/EC) Regulations 2007.

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached[ii]:  United Drug Plc

 

2. Reason for the notification (please tick the appropriate box or boxes):

[ü] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation[iii]: FMR LLC

4. Full name of shareholder(s) (if different from 3.)[iv]: see schedule

5. Date of the transaction and date on which the threshold is crossed or reached[v]: 15 February 2011

6. Date on which issuer notified; 16 February 2011

7. Threshold(s) that is/are crossed or reached: 10%

8. Notified details:

 

 

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii]

Number of Shares[viii]

Number of Voting rights[ix]

Number of shares[x]

Number of voting rights[xi]

% of voting rights

Indirect

Direct[xii]

Indirect[xiii]

Direct

Indirect

IE0033024807

24,112,465

24,112,465

23,612,465

23,612,465

9.79

SUBTOTAL A (based on aggregate voting rights)

24,112,465

24,112,465

23,612,465

23,612,465

9.79

 

B) Financial Instruments

Resulting situation after the triggering transaction[xiv]

Type of financial instrument

Expiration Date[xv]

Exercise/Conversion Period/ Date[xvi]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

SUBTOTAL B (in relation to all expiration dates)

 

Total (A+B)

number of voting rights

% of voting rights

23,612,465

9.97

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable[xvii]: See attached schedule

10. In case of proxy voting: Number of voting rights proxy holder will cease to hold is 500,000.

11. Additional information: None

 

 

 

This announcement has been issued through the Companies Announcement Service of

the Irish Stock Exchange.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISESFAFEAFFSEDE

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00